
11 - 50 employees
Founded 2020
🧬 Biotechnology
🏥 Healthcare
🔬 Science
Biotechnology • Healthcare • Science
Inocras is a clinical genomics company built by scientists and physicians that delivers CAP/CLIA whole‑genome sequencing tests and analytic services for cancer, minimal residual disease (ctDNA), and rare disease diagnosis. Its product suite includes CancerVision (tumor and germline paired whole‑genome tumor profiling), MRDVision (tumor‑informed, whole‑genome ctDNA minimal residual disease detection), and RareVision (whole‑genome rare disease diagnostics). Inocras emphasizes comprehensive detection of SNVs, indels, CNVs, structural variants and non‑coding variants, uses advanced AI and bioinformatics to turn data into clinically actionable insights (including TMB, MSI, HRD, mutational signatures), offers clinical trial matching and genetic counseling support, and serves patients, providers and researchers with a focus on integrating genomic and clinical data at scale.
🔥 2 minutes ago
Director of Business Development for Inocras Inc. expanding revenue-generating opportunities in North America through strategic partnerships and collaboration with multiple teams.